Device Trial Radar · NCT07769489
Study to Assess Tolerability of Injecting Larger Volumes (2-5 mL) Subcutaneously at Different Rates: Participant Experience and Acceptance
Last checked: Nov 21, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Aug 17, 2026
Primary completion
Dec 9, 2026
Study completion Dec 11, 2026
Sponsor
- Lead sponsor
- Novo Nordisk A/SNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to investigate the tolerability of different injection/infusion volumes and speed compared to standard practise. The order in which the different volumes and injection speeds will be given to participants will be allocated by chance. Participants will be in this clinical study for about 1 week.
Conditions
- Healthy Participants
Interventions
Syringe PumpDevice
Device used for delivery of subcutaneous injections and infusions of NaCl solution.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Injection pain rated on a Visual Analogue Scale (VAS)Time frame: 1 minute (±1 minute) from the injection initiation
1 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Novo Nordisk Clinical Innovation Centre A/S
Gentofte Municipality, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.